Basiliximab is superior to low dose rabbit anti-thymocyte globulin in pediatric kidney transplant recipients: The younger, the better

被引:0
|
作者
Zhu Lan [1 ]
Zhang Lei [2 ]
Shang Wenjun [3 ]
Liu Wenhua [4 ]
Sa Rula [1 ]
Guo Zhiliang [1 ]
Liu Longshan [5 ]
Tan Jinghong [5 ]
Zhang Hengxi [5 ]
Feng Yonghua [3 ]
Zhao Wenyu [2 ]
Cong Wenqi [6 ]
Wu Jianyong [6 ]
Wang Changxi [5 ]
Chen Gang [1 ]
机构
[1] Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Key Laboratory of Organ Transplantation, Ministry of Education, NHC Key Laboratory of Organ Transplantation, Key Laboratory of Organ
[2] Department of Organ Transplantation, First Affiliated Hospital, Naval Medical University, Shanghai, China
[3] Department of Renal Transplantation, First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China
[4] Clinical Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
[5] Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
[6] Center of Nephrology, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang,
关键词
D O I
暂无
中图分类号
R726.9 [小儿泌尿科学];
学科分类号
摘要
<正>
引用
收藏
相关论文
共 50 条
  • [1] Basiliximab is superior to low dose rabbit anti-thymocyte globulin in pediatric kidney transplant recipients: The younger, the better
    Zhu, Lan
    Zhang, Lei
    Shang, Wenjun
    Liu, Wenhua
    Sa, Rula
    Guo, Zhiliang
    Liu, Longshan
    Tan, Jinghong
    Zhang, Hengxi
    Feng, Yonghua
    Zhao, Wenyu
    Cong, Wenqi
    Wu, Jianyong
    Wang, Changxi
    Chen, Gang
    CHINESE MEDICAL JOURNAL, 2025, 138 (02) : 225 - 227
  • [2] Comparison of basiliximab to rabbit anti-thymocyte globulin induction in kidney transplant recipients.
    Ahmad, I
    Ketel, B
    Barone, G
    Barri, Y
    Reed, K
    Almquist, G
    Abulezz, S
    TRANSPLANTATION, 2000, 69 (08) : S159 - S159
  • [3] Analysis of rabbit anti-thymocyte globulin vs basiliximab induction in pediatric liver transplant recipients
    Newland, David M.
    Royston, Macy J.
    McDonald, Derry R.
    Nemeth, Thomas L.
    Wallace-Boughter, Kelly
    Carlin, Kristen
    Horslen, Simon
    PEDIATRIC TRANSPLANTATION, 2019, 23 (08)
  • [4] Efficacy and Safety of Single-Dose Rabbit Anti-Thymocyte Globulin versus Basiliximab Induction among Pediatric Kidney Transplant Recipients
    Custodio, L. Porini
    Martins, S. Stopa
    Viana, L. Almeida
    Cristelli, M. Pontello
    Nakamura, M. Rika
    Tedesco-Silva, H.
    Medina-Pestana, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 1013 - 1013
  • [5] Analysis of Rabbit Anti-Thymocyte Globulin versus Basiliximab Induction in Pediatric Liver Transplant Recipients.
    Newland, D.
    Royston, M.
    McDonald, D.
    Wallace-Boughter, K.
    Nemeth, T.
    Carlin, K.
    Horslen, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 730 - 730
  • [6] Comparison of outcomes with low-dose anti-thymocyte globulin, basiliximab or no induction therapy in pediatric kidney transplant recipients: A retrospective study
    Baron, Pedro W.
    Ojogho, Okechukwu N.
    Yorgin, Peter
    Sahney, Shobha
    Cutler, Drew
    Ben-Youssef, Ramzi
    Baqai, Waheed
    Weissman, Jill
    Franco, Edson
    Zuppan, Craig
    Concepcion, Waldo
    PEDIATRIC TRANSPLANTATION, 2008, 12 (01) : 32 - 39
  • [7] Effectiveness of Low versus Standard Dose of Rabbit Anti-Thymocyte Globulin Induction in Kidney Transplant Recipients
    Becker, K.
    Lam, I.
    Kuo, V.
    Perreiter, A.
    Dalin, M.
    Chongkrairatanakul, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S834 - S834
  • [8] A retrospective comparison of the efficacy and safety in kidney transplant recipients with basiliximab and anti-thymocyte globulin
    Wang Wei
    Yin Hang
    Li Xiao-bei
    Hu Xiao-peng
    Yang Xiao-yong
    Liu Hang
    Ren Liang
    Wang Yong
    Zhang Xiao-dong
    CHINESE MEDICAL JOURNAL, 2012, 125 (06) : 1135 - 1140
  • [9] Comparison of basiliximab to rabbit anti-thymocyte globulin induction therapy in African American kidney transplant recipients.
    Mogilishetty, G
    Barone, G
    Kumar, J
    Rekhi, A
    Abul-Ezz, S
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 773A - 773A
  • [10] A retrospective comparison of the efficacy and safety in kidney transplant recipients with basiliximab and anti-thymocyte globulin
    WANG WeiYIN HangLI XiaobeiHU XiaopengYANG XiaoyongLIU HangREN Liang WANG Yong and ZHANG Xiaodong Department of UrologyBeijing ChaoYang HospitalCapital Medical UniversityBeijing China
    中华医学杂志(英文版), 2012, (06) : 1135 - 1140